MAP2K5
MAP2K5
MAP2K5, also known as Mitogen-activated protein kinase kinase 5 or MEK5, is a protein kinase that plays a critical role in the MAPK/ERK signaling pathway. This pathway is essential for various cellular processes, including proliferation, differentiation, and response to external stress signals.
Structure[edit | edit source]
MAP2K5 is a dual-specificity kinase, meaning it can phosphorylate both serine/threonine and tyrosine residues. The gene encoding MAP2K5 is located on chromosome 15 in humans. The protein consists of several domains, including a kinase domain that is responsible for its enzymatic activity.
Function[edit | edit source]
MAP2K5 is primarily involved in the activation of the MAPK7/ERK5 pathway. Upon activation by upstream signals, such as growth factors or stress stimuli, MAP2K5 phosphorylates and activates MAPK7 (also known as ERK5). This activation leads to the regulation of various transcription factors and cellular responses.
Role in Cellular Processes[edit | edit source]
MAP2K5 is implicated in several key cellular processes:
- Cell Proliferation: By activating ERK5, MAP2K5 promotes cell cycle progression and proliferation.
- Cell Differentiation: It plays a role in the differentiation of certain cell types, including neuronal and muscle cells.
- Stress Response: MAP2K5 is involved in cellular responses to oxidative stress and other environmental challenges.
Clinical Significance[edit | edit source]
Alterations in the MAP2K5 gene or its signaling pathway have been associated with various diseases, including cancer and cardiovascular disorders. Overexpression or mutations in MAP2K5 can lead to aberrant cell signaling, contributing to tumorigenesis and metastasis.
Research and Therapeutic Potential[edit | edit source]
Due to its role in critical signaling pathways, MAP2K5 is a potential target for therapeutic intervention. Inhibitors of MAP2K5 are being explored for their potential to treat cancers and other diseases characterized by dysregulated MAPK/ERK signaling.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
